Anne Whitaker is a seasoned healthcare executive with more than 27 years of experience leading high-performance teams to successfully commercialize pharmaceuticals, consumer products and medical devices. Ms. Whitaker currently serves as the CEO of Aerami Therapeutics and as non-executive director on the boards of three public companies, Mallinckrodt, Vectura and CREE. Prior to joining Aerami, Anne served as the chief executive officer and president of KNOW Bio, LLC, a privately held life science company, and the founding chief executive officer of its subsidiary, Novoclem Therapeutics, Inc.